Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: A systematic review and meta-analysis of primary care studies

British Journal of General Practice

Volumn 63, Issue 616, 2013, Pages

  Huang, Yafang ^a   Chen, Rui ^a   Wu, Tao ^b   Wei, Xiaoming ^b   Guo, Aimin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antibiotic prescribing; Meta analysis; Point of care C reactive protein testing; Primary care; Respiratory tract infections

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ARTICLE; CONSULTATION; GENERAL PRACTICE; HUMAN; META ANALYSIS; PATIENT SATISFACTION; POINT OF CARE TESTING; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DRUG PRESCRIPTIONS; FEMALE; GENERAL PRACTICE; HUMANS; MALE; MIDDLE AGED; OBSERVATIONAL STUDY AS TOPIC; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; POINT-OF-CARE SYSTEMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 84887297397     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp13X674477     Document Type: Article

References (31)

1. Thorpe JM, Smith SR, Trygstad TK. Trends in emergency department antibiotic prescribing for acute respiratory tract infections. Ann Pharmacother 2004; 38(6): 928-935. (Pubitemid 38657729)
2. Akkerman AE, Kuyvenhoven MM, van der Wouden JC, Verheij TJ. Prescribing antibiotics for respiratory tract infections by GPs: management and prescriber characteristics. Br J Gen Pract 2005; 55(511): 114-118. (Pubitemid 40246924)
3. Rowbotham S, Chisholm A, Moschogianis S, et al. Challenges to nurse prescribers of a no-antibiotic prescribing strategy for managing self-limiting respiratory tract infections. J Adv Nurs 2012; 68(12): 2622-2632.
4. Tan T, Little P, Stokes T; Guideline Development Group. Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance. BMJ 2008; 337: a437.
5. Kotwani A, Wattal C, Katewa S, et al. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract 2010; 27(6): 684-690.
6. Arnold SR, To T, McIsaac WJ, Wang EE. Antibiotic prescribing for upper respiratory tract infection: the importance of diagnostic uncertainty. J Pediatr 2005; 146(2): 222-226. (Pubitemid 40202813)
7. Falk G, Fahey T. C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies. Fam Pract 2009; 26(1): 10-21.
8. Attia MW. Review: C-reactive protein has moderate diagnostic accuracy for serious bacterial infection in children with fever. Evid Based Med 2009; 14(2): 56.
9. Lindbaek M, Hjortdahl P. The clinical diagnosis of acute purulent sinusitis in general practice: a review. Br J Gen Pract 2002; 52(479): 491-495. (Pubitemid 34578189)
10. Bjerrum L, Gahrn-Hansen B, Munck AP. C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 2004; 54(506): 659-662.
11. Gonzales R, Aagaard EM, Camargo CA Jr, et al. C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm. J Emerg Med 2011; 41(1): 1-7.
12. Llor C, Bjerrum L, Arranz J, et al. C-reactive protein testing in patients with acute rhinosinusitis leads to a reduction in antibiotic use. Fam Pract 2012; 29(6): 653-658.
13. Cals JW, Schot MJ, de Jong SA, et al. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med 2010; 8(2): 124-133.
14. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
15. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25(9): 603-605.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-560. (Pubitemid 37088507)
17. Biggerstaff BJ, Tweedie RL. Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Stat Med 1997; 16(7): 753-768. (Pubitemid 27165681)
18. Fagan MS. [Can use of antibiotics in acute bronchitis be reduced?] (In Norwegian.) Tidsskr Nor Laegeforen 2001; 121(4): 455-458.
19. Cals JW, Ament AJ, Hood K, et al. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. J Eval Clin Pract 2011; 17(6): 1059-1069.
20. Cals JW, Butler CC, Hopstaken RM, et al. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009; 338: b1374.
21. Cals JW, de Bock L, Beckers PJ, et al. Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trial. Ann Fam Med 2013; 11(2): 157-164.
22. Jakobsen KA, Melbye H, Kelly MJ, et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care 2010; 28(4): 229-236.
23. Llor C, Cots JM, López-Valcárcel BG, et al. Interventions to reduce antibiotic prescription for lower respiratory tract infections: Happy Audit study. Eur Respir J 2012; 40(2): 436-441.
24. Kavanagh KE, O'Shea E, Halloran R, et al. A pilot study of the use of near-patient C-Reactive Protein testing in the treatment of adult respiratory tract infections in one Irish general practice. BMC Fam Pract 2011; 12: 93.
25. Diederichsen HZ, Skamling M, Diederichsen A, et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scand J Prim Health Care 2000; 18(1): 39-43. (Pubitemid 30225031)
26. Melbye H, Aaraas I, Fleten N, et al. [The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults.] (In Norwegian.) Tidsskr Nor Laegeforen 1995; 115(13): 1610-1615.
27. Engel MF, Paling FP, Hoepelman AI, et al. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Fam Pract 2012; 29(4): 383-393.
28. Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol 2005; 5: 14.
29. Koopman L, van der Heijden GJ, Glasziou PP, et al. A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses. J Clin Epidemiol 2007; 60(10): 1002-1009.
30. Butler CC, Dunstan F, Heginbothom M, et al. Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract 2007; 57(543): 785-792. (Pubitemid 47595526)
31. Oppong R, Jit M, Smith RD, et al. Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. Br J Gen Pract 2013; 63(612): e465-e471.